LINC00674 and aspergillosis: One advantage of developing therapies targeting integrins would be the possibility of using the developed therapy to treat aspergillosis, since we showed that integrin β1 was also identified as a host receptor on A549 alveolar epithelial cells when interacting with A. fumigatus cell surface protein CalA (24).